Alaunos Therapeutics (TCRT)

• Market cap: $3.92M
• 1 day: 2.94%
• 5 days: -0.81%
• 1 month: 66.67%
• 3 months: 46.71%
• 6 months: 21.29%
• Year to date: 24.37%
• 1 year: -80.56%
• 5 years: -99.42%
• 10 years: -99.81%
• Sector: Healthcare
• Industry: Biotechnology

About: Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.

Employees: 1

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

3% more funds holding

Funds holding: 29 [Q3] → 30 (+1) [Q4]

7.5% less ownership

Funds ownership: 12.0% [Q3] → 4.51% (-7.5%) [Q4]

78% less capital invested

Capital invested by funds: $623K [Q3] → $138K (-$485K) [Q4]

83% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 12